Clementia Pharmaceuticals Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 45

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

Clementia Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company intended for developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical needs. The company's lead product candidate, palovarotene, is an oral small molecule that has shown potent activity in preventing abnormal new bone formation as well as fibrosis in a variety of tissues.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 4150 Ste-Catherine Street West
  • Suite 550
  • Montreal, Quebec H3Z 2Y5
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 4150 Ste-Catherine Street West
  • Suite 550
  • Montreal, Quebec H3Z 2Y5
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clementia Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Clementia Pharmaceuticals‘s full profile, request access.

Request a free trial

Clementia Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended for developing disease-modifying treatments for patients suffering from
Drug Discovery
Montreal, Canada
45 As of 2018

London, United Kingdom
 

Florham Park, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Clementia Pharmaceuticals Competitors (105)

One of Clementia Pharmaceuticals’s 105 competitors is Orchard Therapeutics, a Formerly VC-backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orchard Therapeutics Formerly VC-backed London, United Kingdom
Phathom Pharmaceuticals Formerly VC-backed Florham Park, NJ
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Lexeo Therapeutics Formerly VC-backed New York, NY
Gamida Cell Formerly VC-backed Boston, MA
You’re viewing 5 of 105 competitors. Get the full list »

Clementia Pharmaceuticals Patents

Clementia Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026213691-A1 Methods for treating fibrodysplasia ossificans progressiva Pending 08-Apr-2025
WO-2026213693-A1 Methods for treating fibrodysplasia ossificans progressiva Pending 08-Apr-2025
EP-3893880-A1 Methods for treating heterotopic ossification Inactive 13-Dec-2018
EP-3893880-A4 Methods for treating heterotopic ossification Inactive 13-Dec-2018
US-20220054487-A1 Methods for treating heterotopic ossification Inactive 13-Dec-2018 A61K31/415
To view Clementia Pharmaceuticals’s complete patent history, request access »

Clementia Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clementia Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Clementia Pharmaceuticals‘s full profile, request access.

Request a free trial

Clementia Pharmaceuticals FAQs

  • When was Clementia Pharmaceuticals founded?

    Clementia Pharmaceuticals was founded in 2010.

  • Where is Clementia Pharmaceuticals headquartered?

    Clementia Pharmaceuticals is headquartered in Montreal, Canada.

  • What is the size of Clementia Pharmaceuticals?

    Clementia Pharmaceuticals has 45 total employees.

  • What industry is Clementia Pharmaceuticals in?

    Clementia Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Clementia Pharmaceuticals a private or public company?

    Clementia Pharmaceuticals is a Private company.

  • What is the current valuation of Clementia Pharmaceuticals?

    The current valuation of Clementia Pharmaceuticals is .

  • What is Clementia Pharmaceuticals’s current revenue?

    The current revenue for Clementia Pharmaceuticals is .

  • How much funding has Clementia Pharmaceuticals raised over time?

    Clementia Pharmaceuticals has raised $236M.

  • Who are Clementia Pharmaceuticals’s investors?

    Amplitude Ventures, BDC Capital, EcoR1 Capital, Fonds de solidarite FTQ, and Janus Capital Group are 5 of 11 investors who have invested in Clementia Pharmaceuticals.

  • Who are Clementia Pharmaceuticals’s competitors?

    Orchard Therapeutics, Phathom Pharmaceuticals, Inovio Pharmaceuticals, Lexeo Therapeutics, and Gamida Cell are some of the 105 competitors of Clementia Pharmaceuticals.

  • When was Clementia Pharmaceuticals acquired?

    Clementia Pharmaceuticals was acquired on 18-Apr-2019.

  • Who acquired Clementia Pharmaceuticals?

    Clementia Pharmaceuticals was acquired by Ipsen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process